Professor Bradley’s independent career began in 1992 when he joined the University of Southampton as a Royal Society University Research Fellow (1992-1999). He was awarded a personal chair in Combinatorial Chemistry at the age of 34 and in 1997 founded the Centre for Combinatorial Chemistry. In 2005 he took up his current position at the University of Edinburgh
His work is focused on the application of chemistry to solving medical problems (chemical medicine). His group has published more than 20 patents and 300 articles in the form of papers, reviews and book chapters.
Professor Bradley is the recipient of numerous international awards and prizes including the Novartis lectureship, election to fellowship of the Royal Society of Edinburgh and Fellowship of the Royal Society of Chemistry, the Chancellors Award (the highest research award of the University of Edinburgh) and the 2015 RSC Tilden Prize. He holds an ERC Advanced grant. He was co-founder of Ilika Technologies (2004), which floated on AIMS in 2010. In 2010 he was a co-founder of the spin-out DestiNA Technologies and in March 2014 he was a founder of Edinburgh Molecular Imaging. He is Director of a $25M Interdisciplinary Research Collaboration in the area of Optical Molecular Imaging (Proteus 2014-2023). He is also PI on a Doctorial Training Centre (60 PhD’s) in Optical Imaging with Entrepreneurship and holds an ERC advanced grant on “SmartMaterials” for cellular control.
